Invention Grant
- Patent Title: Use of gram negative species to treat atopic dermatitis
-
Application No.: US16249721Application Date: 2019-01-16
-
Publication No.: US10682379B2Publication Date: 2020-06-16
- Inventor: Ian Antheni Myles , Sandip K. Datta
- Applicant: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Applicant Address: US MD Bethesda
- Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Current Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Current Assignee Address: US MD Bethesda
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K35/74
- IPC: A61K35/74 ; A61P17/04 ; A61K9/00 ; A61K9/06
Abstract:
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
Public/Granted literature
- US20190142874A1 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS Public/Granted day:2019-05-16
Information query
